Compounds > bupranolol

bupranolol and bendroflumethiazide

bupranolol has been researched along with bendroflumethiazide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Dittrich, H; Nagler, J1

Other Studies

2 other study(ies) available for bupranolol and bendroflumethiazide

ArticleYear
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
[Potassium-sparing effect of triamterene in a 3-component combination preparation for the therapy of hypertension].
    Wiener klinische Wochenschrift, 1986, Jan-24, Volume: 98, Issue:2

    Topics: Bendroflumethiazide; Blood Pressure; Bupranolol; Drug Combinations; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Potassium; Propanolamines; Triamterene

1986